Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.7 |
mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |